In the phase 2 EVITA trial, vitamin C did not slow clonal growth but was linked to fewer serious adverse events and longer exploratory survival.
Kirsten Grønbæk, MD, PhD
Advertisement
Articles by Kirsten Grønbæk, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Breast Cancer Awareness: An APN on Personalized Care and Survivorship
2
FDA Approves Atezolizumab Plus Chemo for Stage 3 dMMR Colon Cancer
3
Navigation Boosts Cascade Genetic Testing in Relatives of BRCA Carriers
4
Daily Symptom Shifts Linked to Quality of Life in Metastatic Breast Cancer
5